Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Baldin

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Future Microbiology|February 15, 2022
3,5-dinitrobenzoylhydrazone derivatives as a scaffold for antituberculosis drug developmentTamires L Valverde, Eloísa G Sampiron, Débora C Montaholi, et al.
Future Microbiology|November 20, 2020
(-)-Camphene-based derivatives as potential antibacterial agents against <i>Staphylococcus aureus</i> and <i>Enterococcus</i> sppBeatriz C de Freitas, Paula A Queiroz, Vanessa P Baldin, et al.
Infectious Disorders Drug Targets|January 26, 2018
New insights on Ethambutol Targets in Mycobacterium tuberculosisLuciana D Ghiraldi-Lopes, Paula A Zanetti Campanerut-Sá, Geisa P Caprini Evaristo, et al.
Future Microbiology|June 8, 2018
Carvacrol activity & morphological changes in Mycobacterium tuberculosisSandra S Nakamura de Vasconcelos, Katiany R Caleffi-Ferracioli, Laíse A Hegeto, et al.
Future Microbiology|August 7, 2019
Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agentsEloísa G Sampiron, Giovana F Costacurta, Vanessa P Baldin, et al.
Future Microbiology|July 21, 2020
Synthesis and biological evaluation of 12 novel (-)-camphene-based 1,3,4-thiadiazoles against <i>Mycobacterium tuberculosis</i>Giovana F Costacurta, Mariana Rp Souza, Eloísa G Sampiron, et al.
Future Microbiology|February 14, 2019
Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteriaAryadne L de Almeida, Katiany R Caleffi-Ferracioli, Regiane B de L Scodro, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Future Microbiology|February 15, 2022
3,5-dinitrobenzoylhydrazone derivatives as a scaffold for antituberculosis drug developmentTamires L Valverde, Eloísa G Sampiron, Débora C Montaholi, et al.
Future Microbiology|November 20, 2020
(-)-Camphene-based derivatives as potential antibacterial agents against <i>Staphylococcus aureus</i> and <i>Enterococcus</i> sppBeatriz C de Freitas, Paula A Queiroz, Vanessa P Baldin, et al.
Infectious Disorders Drug Targets|January 26, 2018
New insights on Ethambutol Targets in Mycobacterium tuberculosisLuciana D Ghiraldi-Lopes, Paula A Zanetti Campanerut-Sá, Geisa P Caprini Evaristo, et al.
Future Microbiology|June 8, 2018
Carvacrol activity & morphological changes in Mycobacterium tuberculosisSandra S Nakamura de Vasconcelos, Katiany R Caleffi-Ferracioli, Laíse A Hegeto, et al.
Future Microbiology|August 7, 2019
Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agentsEloísa G Sampiron, Giovana F Costacurta, Vanessa P Baldin, et al.
Future Microbiology|July 21, 2020
Synthesis and biological evaluation of 12 novel (-)-camphene-based 1,3,4-thiadiazoles against <i>Mycobacterium tuberculosis</i>Giovana F Costacurta, Mariana Rp Souza, Eloísa G Sampiron, et al.
Future Microbiology|February 14, 2019
Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteriaAryadne L de Almeida, Katiany R Caleffi-Ferracioli, Regiane B de L Scodro, et al.
Pageof 2